FDA Investigator LCDR William H Bender
LCDR William H Bender has inspections in 1 countries as of 24 Aug 2023. LCDR William H Bender has collaborated with a combined 950 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
101
Last Inspection Date:
24 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
A Williams,
Brandon J Brookens,
Brandon M Kurjanowicz,
Brian M Palermo,
Carl E Lovrich,
Chamberlain,
Christina K Theodorou,
Christine I Shaw,
Crayton Lee,
Crystal A Harlan,
Cynthia L Rakestraw,
Daniel J Mechenbier,
Daniel R Rammariello,
Daniel R Tammariello,
Dauksism,
David L Pearce,
Dennis R Hock,
Dessa A Antoine,
Dougherty,
Dr. Mark J Seaton, PhD,
Erica L Nicoll,
Gale L Glinecki,
Gess,
Gladys B Casper,
Gregory E Beichner,
James M Odonnell,
Joseph R Hatcher,
Joshua E Yao,
Kailee R Mason,
Karen S Anthony,
Katelyn Astaub Zamperini,
Kirk A Dymbrowski,
LCDR Susan E Polifko,
LT John M Mastalski,
LTJG Bradley E Benasutti,
Marjorie L Davis,
Mary E Storch,
Mary R Kirker,
Mastalskij,
Maureen A Wentzel,
Michael J Diskin,
Michael L Casner,
Michael R Goga,
Michael R Klapal,
Myrick,
Robert E Davis,
State Agency,
Tammy M Phillips,
Thomas R Withers,
Thompsonv,
Tiffani D Wilson,
Travers,
Travis R Hunt,
Van Cliff,
William A Warnick,
William C Brenneman
LCDR William H Bender's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2004 | FDA 483 | UNFI Pittsburgh Division - Form 483, 2004-12-07 |
December, 2002 | FDA 483 | Gatti Health Care Inc - Form 483, 2002-12-23 |
August, 2003 | EIR | Philips Respironics, Inc. - EIR, 2003-08-15 |
October, 2003 | EIR | Novum Pharmaceutical Research Services of Pennsylvania, Inc. - EIR, 2003-10-29 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more